FLT3 Mutation Testing in Acute Myeloid Leukemia

JAMA Oncol. 2017 Jul 1;3(7):991-992. doi: 10.1001/jamaoncol.2017.0257.

Authors

Arjun Gupta¹, David S Viswanatha², Mrinal M Patnaik³

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
³ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

PMID: 28358966
DOI: 10.1001/jamaoncol.2017.0257

No abstract available

Publication types

Case Reports

MeSH terms

Cytarabine / therapeutic use
Daunorubicin / therapeutic use
Genetic Testing / methods*
Headache / etiology
Humans
Leukapheresis
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics
Leukostasis / diagnosis*
Leukostasis / genetics
Leukostasis / therapy
Male
Middle Aged
Segmental Duplications, Genomic*
Tandem Repeat Sequences
Vision Disorders / etiology
fms-Like Tyrosine Kinase 3

Substances

Cytarabine
FLT3 protein, human
fms-Like Tyrosine Kinase 3
Daunorubicin